Dr. George Park is a neurologist by residency training and has become an indispensable part of the Neuro-Ophthalmology team. He has expertise in a wide array of neuro-ophthalmologic conditions, including those related to optic neuritis and underlying demyelinating disorders such as multiple sclerosis, idiopathic intracranial hypertension, and all causes of vision loss related to optic nerve and brain problems. He has a particular interest in double vision along with abnormal eye movements such as seen in conditions such as myasthenia gravis. He is a member of the American Board of Neurology and American Board of Psychiatry and Neurology.
- NYU Langone Medical Center, Neuro-Ophthalmology Fellowship
- NYU Langone Medical Center, Neurology Residency
- Michigan State University College of Osteopathic Medicine, DO
Education & Training
A Great Conversation With Edmond J. FitzGibbon. Calix RA, Park GT, Digre KB. J Neuroophthalmol. 2025 Jun 1;45(2):e153-e159. doi: 10.1097/WNO.0000000000002339. Epub 2025 Mar 27.
A Great Conversation With Alfredo Sadun. Calix RA, Park GT, Digre KB. J Neuroophthalmol. 2025 Mar 1;45(1):e81-e93. doi: 10.1097/WNO.0000000000002323. Epub 2025 Jan 23.
A Great Conversation With Steven Galetta. Park GT, Calix RA, Dugue AG, Digre KB. J Neuroophthalmol. 2024 Dec 1;44(4):e512-e519. doi: 10.1097/WNO.0000000000002284.
Distinguishing Between Myelin Oligodendrocyte Glycoprotein Disease Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy. Park GT, Galetta S.
Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200240. doi: 10.1212/NXI.0000000000200240. Epub 2024 Mar 28.
Subacute Vision Loss in a Patient With HIV. Park GT, Gold DM, Modi Y, Rucker JC. J Neuroophthalmol. 2024 Mar 1;44(1):e200. doi: 10.1097/WNO.0000000000002012. Epub 2023 Nov 23.
Dr. Park's research interests involve improving diagnostic mechanisms for sideline recognition of TBI. He is also passionate about teaching the medical community, residents, and medical students in the prompt and accurate diagnosis of neuro-ophthalmologic disorders. Additionally, he is collaborating with basic science colleagues groundbreaking research on novel technologies and tools aiding in the clinical diagnosis of nystagmus+ involuntary eye movements caused by neurologic disorders.